Delivery Order SPE2DB24D3013-SPE2DB26FFGAQ
- Not listed
- The Defense Logistics Agency awarded a $1,944.90 delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10 mL) on July 18, 2025, with completion scheduled for July 21, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor specializing in medical supply chain support for military and veteran healthcare...
- The Defense Logistics Agency awarded a $1,749.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10 mL) on September 25, 2025, with completion scheduled for September 26, 2025. This non-set-aside contract represents a routine pharmaceutical procurement issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $2,765.03 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vial 10mL insulin medication on August 21, 2025, with completion scheduled for August 22, 2025. This competitive award, issued under firm fixed pricing terms, represents a routine pharmaceutical supply transaction supporting military healthcare operations. The award was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $1,944.90 delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10mL) with a firm fixed price structure and completion date of September 15, 2025. This is an unset-aside, competitively awarded contract issued on September 12, 2025, with performance to be completed at the vendor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $14,934.45 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10mL) with a firm fixed price structure and completion date of October 31, 2025. This non-set-aside contract was competitively awarded and represents a single delivery order fulfillment for insulin pharmaceutical supply to support federal medical procurement needs. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $6,073.00 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10mL units), with an ultimate completion date of June 26, 2025. This non-competitive delivery order employs firm fixed pricing and represents a continuation of pharmaceutical supply support to federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor in the federal medical supply...
- The Defense Logistics Agency awarded a delivery order valued at $5,186.40 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10mL) on September 16, 2025, with completion scheduled for September 17, 2025. This firm fixed-price delivery order was awarded without set-aside designation through competitive procurement. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania, supporting the agency's medical supply...
- The Defense Logistics Agency awarded a delivery order valued at $2,372.92 to AmerisourceBergen Drug Corp for the supply of NovoLog 100 Unit/mL vials (10 mL) on June 18, 2025, with an ultimate completion date of June 20, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open procurement. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,696.30 for NovoLog 100 Unit/ML vials (10 mL) on August 8, 2025, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded a $2,540.18 delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of NovoLog 100 Unit/mL vials (10 mL). The contract, which employs firm fixed-price terms, is scheduled for completion by October 28, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside competitive award, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB26FFGAQDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,994.41 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10mL) with a firm fixed price and an ultimate completion date of November 3, 2025. The award, made on October 31, 2025, is a non-set-aside competitive contract for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for the Defense Logistics Agency's Medical Supply Chain and fulfills pharmaceutical requirements across military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The prime contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including support to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The delivery order represents a routine fulfillment of insulin products under this expansive contract framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 10/31/25 |